Stay updated on Lenvatinib and Pembrolizumab in DTC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in DTC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A banner was added announcing NIH website changes and saying that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T13:08:19.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-18T13:19:25.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site revision label in the footer changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:10:04.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error rather than the study details, indicating access is blocked or restricted. This prevents viewing the trial information while the underlying data remains unchanged.
    Difference
    20%
    Check dated 2026-09-20T12:28:39.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, signaling a new site build or update for the study details page.
    Difference
    0.0%
    Check dated 2026-08-29T23:46:18.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    The page’s revision label was updated to v3.6.5, indicating a new maintenance release of the study page. No study details or content appear to have changed as part of this update.
    Difference
    0.0%
    Check dated 2026-08-08T23:14:16.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.